While STING agonists in clinical trials generally are associated with mild adverse effects such as pyrexia, injection site pain, and diarrhea [193], new side effects like kidney dysfunction were observed in C57BL/6 mice following STING activation. This evidence concerns the gene STING1 and Fever.